Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • adrien.andre
    Junior Member
    • Jan 2016
    • 2

    subsampling before/after contaminant removing?

    Hi,
    I've got some 16S sequences obtained with a miseq sequencer.
    I have sequenced several negative control samples to identify contaminants that I have to remove them from my actual samples.
    I was thinking about deleting the contaminated OTU from each sample if its number of reads is not present 10x more than in the highest contaminated negative control.
    in short, if I have this pattern for OTU x :
    sample A : 20 reads
    Sample B : 300 reads
    Negative control C : 3 reads
    Negative control D : 12 reads

    I will delete this OTU for sample A but not for sample B as 300> 120

    This being said, here is my question :
    When should the sub-sampling being performed? should it be before or after removing the contaminants?

    I was first thinking about subsampling after the contaminant removing step.
    but then, I thought that the rule for removing contaminant stated previously should be efficient only in a subsampled dataset.

    therefore, should i rather subsample before removing the contaminants? But then, the problem is that some samples are way more contaminated than others, which means that the resulting sequencing depth will vary from a sample to another...

    Or should I subsample twice? before AND after?

    Thank you in advance for your precious advices

    Adrien

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    Yesterday, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:10 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...